S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 NeuralstemGene BiotherapeuticsTengionAVAX TechnologiesCornwall Resources
SymbolNASDAQ:CUROTCMKTS:CRXMOTCMKTS:TNGNQOTCMKTSMKTS:AVXTOTCMKTS:CORC
Price Information
Current Price$1.34$0.05$0.01N/A$0.00
52 Week RangeN/AN/AN/AN/AN/A
MarketRank™
Overall Score0.80.60.30.00.0
Analysis Score0.00.00.00.00.0
Community Score2.52.40.00.00.0
Dividend Score0.00.00.00.00.0
Ownership Score0.80.81.70.00.0
Earnings & Valuation Score0.60.00.00.00.0
Analyst Ratings
Consensus RecommendationN/AN/AN/AN/AN/A
Consensus Price TargetN/AN/AN/AN/AN/A
% Upside from Price TargetN/AN/AN/AN/AN/A
Trade Information
Market Cap$2.81 million$652,000.00N/AN/AN/A
Beta1.811.31.89-4.1N/A
Average Volume236,278533,326405,917616,888100
Sales & Book Value
Annual Revenue$260,000.00N/AN/AN/AN/A
Price / Sales10.82N/AN/AN/AN/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$6.64 per shareN/AN/AN/AN/A
Price / Book0.20N/AN/AN/AN/A
Profitability
Net Income$-4,930,000.00N/AN/AN/AN/A
EPSN/AN/AN/AN/AN/A
Trailing P/E Ratio0.000.000.000.000.00
Forward P/E RatioN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-39,417.64%N/AN/AN/AN/A
Return on Equity (ROE)-170.51%N/AN/AN/AN/A
Return on Assets (ROA)-110.16%N/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/AN/AN/A
Current Ratio2.53%N/AN/AN/AN/A
Quick Ratio2.53%N/AN/AN/AN/A
Ownership Information
Institutional Ownership Percentage38.30%N/AN/AN/AN/A
Insider Ownership Percentage5.38%49.80%86.59%6.00%18.40%
Miscellaneous
Employees66259N/A
Shares Outstanding2.10 million14.49 millionN/AN/A186,000
Next Earnings DateN/AN/AN/AN/AN/A
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.